<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01431443</url>
  </required_header>
  <id_info>
    <org_study_id>IC096501</org_study_id>
    <nct_id>NCT01431443</nct_id>
  </id_info>
  <brief_title>Consumption of Chocolate in Pregnant Women.</brief_title>
  <acronym>CHOCENTA</acronym>
  <official_title>Consumption of Chocolate in Pregnant Women at High Risk for Preeclampsia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the acute and chronic effect of consumption of
      flavanol-rich chocolate on endothelium function in pregnant women at high risk for
      preeclampsia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although numerous strategies have been studied, no effective prevention or treatment of
      preeclampsia is yet available for pregnant women. This is surprising considering the growing
      body of literature that supports the hypothesis of a beneficial effect of dark chocolate
      consumption through the activity of flavanols on the endothelial function and blood pressure
      regulation, to find any clinical data among pregnant women with preeclampsia.

      The primary objective of the trial is to investigate the acute and chronic effect of
      consumption of flavanol-rich chocolate on endothelial function in pregnant women at high risk
      of preeclampsia. This 12-week efficacy study will permit us to verify the sustainability of
      the effect of daily intake of flavanol-rich chocolate intake.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in endothelial function</measure>
    <time_frame>within the first 12 weeks of chocolate intake</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Doppler of uterine arteries</measure>
    <time_frame>within the first 12 weeks of chocolate intake</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>within the first 12 weeks of chocolate intake</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma biomarker of endothelium function</measure>
    <time_frame>within the first 12 weeks of chocolate intake</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma biomarker of chocolate intake</measure>
    <time_frame>within the first 12 weeks of chocolate intake</time_frame>
    <description>ng\ml plasma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>Dark chocolate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo chocolate</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flavanol-rich chocolate</intervention_name>
    <description>The aim of this study is to evaluate the beneficial effect of dark chocolate consumption through the activity of flavanols on the endothelial function and blood pressure regulation, in acute (after 3 hours) and chronic effect (12 weeks), among pregnant women at high risk for preeclampsia.</description>
    <arm_group_label>Dark chocolate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Chocolate</intervention_name>
    <description>Placebo intervention</description>
    <arm_group_label>Placebo chocolate</arm_group_label>
    <other_name>Flavanol and theobromine-free chocolate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women between the ages of 18 and 40 years.

          -  Presence of uterine diastolic notches measured by uterine artery Doppler between 10
             and 14 weeks.

        Exclusion Criteria:

          -  Hypertension requiring medication.

          -  Currently or previously use of medications interfering with glucose or lipids
             metabolism.

          -  Use of supplements or natural health products that interfere with blood pressure.

          -  Consumption of 1 or more alcohol drink per day.

          -  Allergy or intolerance to nuts or chocolate.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvie Dodin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels.</name>
      <address>
        <city>Qu√©bec</city>
        <state>Quebec</state>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2011</study_first_submitted>
  <study_first_submitted_qc>September 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2011</study_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Randomized double blind trial</keyword>
  <keyword>Cocoa flavonoids</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Pregnant women</keyword>
  <keyword>Preeclampsia</keyword>
  <keyword>Uterine artery flow</keyword>
  <keyword>Pulsatility index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

